`Sent:
`To:
`
`Cc:
`Subject:
`
`Cunningham, Laura
`Tuesday, September 23, 2014 9:31 PM
`Amanda Hollis (amanda.hollis@kirkland.com); De Vries, Mike W.; Cutri, Elizabeth A.; J.
`Mitchell Jones; Holland, Elizabeth J.; Hardman, Cynthia Lambert
`Farmer, Dean; Graves, Jon
`IPR2014-00003
`
`Counsel:
`
`Pursuant to 37 C.F.R. 42.64(b)(1), Neptune hereby provides notice of its objections to AKBM Ex. 1107, which was served
`with Petitioners’ Reply on September 18, 2014. The correspondence between Neptune and the FDA contained in Ex.
`1107 is irrelevant to the alleged anticipation by Beaudoin, and Petitioners’ argument regarding this exhibit is misleading.
`Neptune intends to move to exclude this exhibit pursuant to Federal Rules of Evidence 402 and/or 403.
`
`Neptune is willing to meet and confer with Petitioners regarding its objections if Petitioners wish to do so.
`
`Regards,
`Laura
`
`Laura J. Cunningham
`Cooley LLP
`1299 Pennsylvania Avenue, NW • Suite 700
`Washington, DC 20004-2400
`Direct: +1 202 728 7072 • Fax: +1 202 842 7899
`Email: lcunningham@cooley.com • www.cooley.com
`
`Admission to the DC bar pending
`
`
`
`1
`
`NEPN Ex. 2065
`Aker v. Neptune
`IPR2014-00003